Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2018 at "American journal of ophthalmology"
DOI: 10.1016/j.ajo.2018.05.008
Abstract: PURPOSE To quantify the extent of topographic correspondence between baseline (BSL) choroidal neovascularization (CNV) and macular atrophy (MA) at follow-up in eyes with neovascular age-related macular degeneration (NVAMD). DESIGN Post hoc analysis of randomized controlled…
read more here.
Keywords:
trial;
macular atrophy;
cnv;
topographic correspondence ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Ophthalmology"
DOI: 10.1016/j.ophtha.2019.11.016
Abstract: PURPOSE To report the natural history of untreated neovascular age-related macular degeneration (nAMD) regarding subsequent macular atrophy. DESIGN Prospective cohort within a randomized, controlled trial of oral micronutrient supplements. PARTICIPANTS Age-Related Eye Disease Study (AREDS)…
read more here.
Keywords:
atrophy;
standard error;
macular atrophy;
age related ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Retina"
DOI: 10.1097/iae.0000000000003463
Abstract: Extensive macular atrophy with pseudodrusen is preceded by subretinal deposits that progressively disappear with accumulation of subretinal pigment epithelium midreflective material creating an RPE–basal lamina–Bruch membrane separation with a discernible Bruch membrane. These changes may…
read more here.
Keywords:
macular atrophy;
atrophy pseudodrusen;
extensive macular;
foveal sparing ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Retina"
DOI: 10.1097/iae.0000000000003683
Abstract: Supplemental Digital Content is Available in the Text. Disruption of the ellipsoid zone over areas of retinal pigment epithelium–Bruch membrane separation represents the first disease alteration found in extensive macular atrophy with pseudodrusen-like appearance. The…
read more here.
Keywords:
macular atrophy;
atrophy pseudodrusen;
extensive macular;
atrophy ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Retina"
DOI: 10.1097/iae.0000000000003733
Abstract: Extensive macular atrophy with pseudodrusen shows remarkable clinical and imaging similarities with the diffuse-trickling pattern of geographic atrophy. Using a quantitative approach, we investigated whether extensive macular atrophy with pseudodrusen and diffuse-trickling pattern of geographic…
read more here.
Keywords:
macular atrophy;
atrophy pseudodrusen;
autofluorescence;
extensive macular ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2017 at "Medicine"
DOI: 10.1097/md.0000000000006422
Abstract: Background: To evaluate the efficacy and safety of topical isopropyl unoprostone (IU) in treating macular atrophy in age-related macular degeneration (AMD) patients. Methods: Fifty-two AMD patients with macular atrophy were included and randomly assigned (1:1)…
read more here.
Keywords:
topical isopropyl;
age related;
group;
macular atrophy ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
1
Published in 2022 at "Acta Ophthalmologica"
DOI: 10.1111/aos.15309
Abstract: The purpose of the study was to assess the association of macular atrophy (MA) according to the activity of macular neovascularization (MNV) (inactive, only subretinal fluid [SRFL], or active, i.e. including intraretinal fluid [IRFL]) using…
read more here.
Keywords:
related macular;
macular atrophy;
age related;
subretinal fluid ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2018 at "British Journal of Ophthalmology"
DOI: 10.1136/bjophthalmol-2018-311963
Abstract: Background/aims To evaluate the 5-year visual and anatomical outcomes after anti-vascular endothelial growth factor (VEGF) therapy alone or in combination with photodynamic therapy (PDT), followed by pro re nata (PRN) anti-VEGF therapy with or without…
read more here.
Keywords:
anti vegf;
year;
macular atrophy;
therapy without ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2018 at "British Journal of Ophthalmology"
DOI: 10.1136/bjophthalmol-2018-312430
Abstract: Background/aims To investigate the factors associated with macular atrophy (MA) growth rates in neovascular age-related macular degeneration treated with either ranibizumab or aflibercept. Methods We obtained data from two identical prospective studies using ranibizumab or…
read more here.
Keywords:
growth rates;
age;
macular atrophy;
ranibizumab aflibercept ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2019 at "British Journal of Ophthalmology"
DOI: 10.1136/bjophthalmol-2019-315055
Abstract: Background To assess the prevalence and characteristics associated with macular atrophy (MA) in eyes with neovascular age-related macular degeneration (nAMD) treated with vascular endothelial growth factor (VEGF) inhibitors. Methods This was a retrospective, cross-sectional study…
read more here.
Keywords:
eyes neovascular;
prevalence characteristics;
age;
atrophy eyes ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2020 at "European Journal of Ophthalmology"
DOI: 10.1177/1120672120948730
Abstract: Dear Editor, We would like to address several issues with the study by Oliveira et al.1 First, there was a selection bias assigned to the fact that four patient groups using different antiangiogenic agents (ranibizumab…
read more here.
Keywords:
atrophy development;
macular atrophy;
age related;
related macular ... See more keywords